Citations

Showing 10 of 108135 citations.

Auricular Cartilage Resection for Treatment-Refractory Idiopathic Chronic Chondritis: A Case Series
Gordon, Steven A., Nassiri, Ashley M., Driscoll, Colin L., Carlson, Matthew L., Patel, Neil S., Gordon, Steven A., Nassiri, Ashley M., Driscoll, Colin L., Carlson, Matthew L., Patel, Neil S.

Mayo Clinic

Otology & Neurotology | October 6, 2021 | Volume: 43 | Issue: 1 | Pages: e92-e96

10.1097/mao.0000000000003358 | PMID 34889844 Get It

Objective: Describe a series of cases of idiopathic chronic auricular chondritis refractory to antibiotics and steroids treated successfully with surgery. Study Design: Case series. Setting: Two tertiary academic medical centers. Patients: We analyzed four patients diagnosed with chronic auricular deformity, pain, and drainage for a period of 1 to 5 years who had failed prolonged treatment consisting of antibiotics, corticosteroids, and incision and drainage. All four patients were smokers, three were diabetic, and two had a history of bariatric surgery. Interventions: Operative subcutaneous partial auriculectomy (removal of diseased cartilage and excess skin) was performed. Main Outcome Measures: Resolution of pain and drainage, need for additional procedures, and reduction in narcotics required for pain control were analyzed. Results: Two of the four patients were given an immediate postoperative course of doxycycline and ciprofloxacin. With a minimum of 6 weeks’ follow-up, all four patients had complete resolution of pain and recurrent drainage postoperatively. One patient requiring daily narcotic medication for pain and benzodiazepine for sleep preoperatively no longer required prescription medication. All specimens revealed chronic dermal and cartilage inflammation. Three of four cases had polymicrobial infection. One case had only skin contaminant growth on culture following multiple oral and parental antibiotic regimens. Conclusions: Surgical excision of diseased cartilage as a result of idiopathic chronic chondritis is an effective treatment in those cases refractory to antibiotics and incision and drainage, and should be considered in the treatment algorithm for similar patients, potentially offering definitive cure.
Adenomyoma Versus Leiomyoma: Not All Uterine Lesions Are the Same
Cope, Adela G. , Callahan, Nicole , Khan, Zaraq , Burnett, Tatnai L.

Mayo Clinic

Videoscopy | October 6, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/vor.2021.0042 Get It

Evaluation of Piperacillin-Tazobactam for Antibiotic Prophylaxis in Traumatic Grade III Open Fractures
O’Connell, Casey, Kooda, Kirstin , Sawyer, Mark D. , Wise, Kevin B., Mara, Kristin C. , Skrupky, Lee P. , O'Connell, Casey R, Kooda, Kirstin J, Mara, Kristin C , Skrupky, Lee P

Mayo Clinic

Surgical Infections | October 6, 2021 | Volume: 23 | Issue: 1 | Pages: 41-46

10.1089/sur.2021.122 | PMID 34612703 Get It

Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
Navaratnarajah, Chanakha K. , Pease, David R. , Halfmann, Peter , Barkhymer, Alison , Howell, Kyle G., Charlesworth, Jon E. , Christensen, Trace , Kawaoka, Yoshihiro , Cattaneo, Roberto , Schneider, Jay W. , Taye, Biruhalem , Cattaneo, Roberto , Schneider, Jay W , Halfmann, Peter J

Mayo Clinic

Journal of Virology | October 6, 2021 | Volume: 95 | Issue: 24 | Pages: No page available

10.1128/jvi.01368-21 | PMID 34613786 Get It

Cardiac complications frequently observed in COVID-19 patients are tentatively attributed to systemic inflammation and thrombosis, but viral replication has occasionally been confirmed in cardiac tissue autopsy materials. We developed an in vitro model of SARS-CoV-2 spread in myocardium using induced pluripotent stem cell-derived cardiomyocytes.
Dose of Cardiac Rehabilitation to Reduce Mortality and Morbidity: A Population‐Based Study
Medina‐Inojosa, José R. , Grace, Sherry L. , Supervía, Marta , Stokin, Gorazd B. , Bonikowske, Amanda R. , Thomas, Randal J. , López-Jiménez, Francisco , Stokin, Gorazd , Thomas, Randal , Grace, Sherry L , Lopez-Jimenez, Francisco , Medina-Inojosa, José R

Mayo Clinic

Journal of the American Heart Association | October 6, 2021 | Volume: 10 | Issue: 20 | Pages: No page available

10.1161/jaha.120.021356 | PMID 34612055 Get It

Background There is wide variability in cardiac rehabilitation (CR) dose (ie, number of sessions) delivered, and no evidence‐based recommendations regarding what dose to prescribe. We aimed to test what CR dose impacts major adverse cardiovascular events (MACEs). Methods and Results This is an historical cohort study of all patients who had coronary artery disease and who initiated supervised CR between 2002 and 2012 from a single major CR center. CR dose was defined as number of visits including exercise and patient education. Follow‐up was performed using record linkage from the Rochester Epidemiology Project. MACEs included acute myocardial infarction, unstable angina, ventricular arrhythmias, stroke, revascularization, or all‐cause mortality. Dose was analyzed in several ways, including tertiles, categories, and as a continuous variable. Cox models were adjusted for factors associated with dose and MACE. The cohort consisted of 2345 patients, who attended a mean of 12.5±11.1 of 36 prescribed sessions. After a mean follow‐up of 6 years, 695 (29.65%) patients had a MACE, including 231 who died. CR dose was inversely associated with MACE (hazard ratio, 0.66 [95% CI]; 0.55–0.91) in those completing ≥20 sessions, when compared with those not exposed to formal exercise sessions (≤1 session; log‐rank P =0.007). We did not find evidence of nonlinearity ( P ≥0.050), suggesting no minimal threshold nor ceiling. Each additional session was associated with a lower rate of MACE (fully adjusted hazard ratio, 0.98 [95% CI, 0.97–0.99]). Greater session frequency was also associated with lower MACE risk (fully adjusted hazard ratio, 0.74 [95% CI, 0.58–0.94]). Conclusions CR reduces MACEs, but the benefit appears to be linear, with greater risk reduction with higher doses, and no upper threshold.
Tracking Blood Pressure Control Performance and Process Metrics in 25 US Health Systems: The PCORnet Blood Pressure Control Laboratory
Cooper‐DeHoff, Rhonda M. , Fontil, Valy, Carton, Thomas, Chamberlain, Alanna M. , Todd, Jonathan, O’Brien, Emily C., Shaw, Kathryn M., Smith, Myra, Choi, Sujung, Nilles, Ester K., Ford, Daniel, Tecson, Kristen M. , Dennar, Princess E., Wu, Shenghui, McClay, James C. , Azar, Kristen , Singh, Rajbir, Modrow, Madelaine Faulkner, Shay, Christina M., Wozniak, Gregory, Pletcher, Mark J. , Nilles, Ester Kim , Modrow, Madelaine Faulkner , Ahmad, Faraz , McClay, James , Azar, Kristen , Rakotz, Michael , Pletcher, Mark J , Chamberlain, Alanna M , Faulkner Modrow, Madelaine , Cooper‐DeHoff, Rhonda M. , Fontil, Valy, Carton, Thomas, Todd, Jonathan, O’Brien, Emily C., Shaw, Kathryn M., Smith, Myra, Choi, Sujung, Ford, Daniel, Tecson, Kristen M. , Dennar, Princess E., Wu, Shenghui, Singh, Rajbir, Shay, Christina M., Wozniak, Gregory

Mayo Clinic

Journal of the American Heart Association | October 6, 2021 | Volume: 10 | Issue: 21 | Pages: No page available

10.1161/jaha.121.022224 | PMID 34612048 Get It

Background The National Patient‐Centered Clinical Research Network Blood Pressure Control Laboratory Surveillance System was established to identify opportunities for blood pressure (BP) control improvement and to provide a mechanism for tracking improvement longitudinally. Methods and Results We conducted a serial cross‐sectional study with queries against standardized electronic health record data in the National Patient‐Centered Clinical Research Network (PCORnet) common data model returned by 25 participating US health systems. Queries produced BP control metrics for adults with well‐documented hypertension and a recent encounter at the health system for a series of 1‐year measurement periods for each quarter of available data from January 2017 to March 2020. Aggregate weighted results are presented overall and by race and ethnicity. The most recent measurement period includes data from 1 737 995 patients, and 11 956 509 patient‐years were included in the trend analysis. Overall, 15% were Black, 52% women, and 28% had diabetes. BP control (<140/90 mm Hg) was observed in 62% (range, 44%–74%) but varied by race and ethnicity, with the lowest BP control among Black patients at 57% (odds ratio, 0.79; 95% CI, 0.66–0.94). A new class of antihypertensive medication (medication intensification) was prescribed in just 12% (range, 0.6%–25%) of patient visits where BP was uncontrolled. However, when medication intensification occurred, there was a large decrease in systolic BP (≈15 mm Hg; range, 5–18 mm Hg). Conclusions Major opportunities exist for improving BP control and reducing disparities, especially through consistent medication intensification when BP is uncontrolled. These data demonstrate substantial room for improvement and opportunities to close health equity gaps.
To understand a meta‐analysis, best read the fine print
Greason, Kevin L.

Mayo Clinic

Journal of Cardiac Surgery | October 6, 2021 | Volume: 36 | Issue: 12 | Pages: 4743-4745

10.1111/jocs.16050 | PMID 34608675 Get It

Superiority of urgent vs early endoscopic hemostasis in patients with upper gastrointestinal bleeding with high-risk stigmata
Horibe, Masayasu , Iwasaki, Eisuke , Matsuzaki, Juntaro , Bazerbachi, Fateh , Kaneko, Tetsuji , Minami, Kazuhiro , Fukuhara, Seiichiro , Masaoka, Tatsuhiro , Namiki, Shin, Hosoda, Yasuo , Ogata, Haruhiko , Bazerbachi, F , Hosoe, Naoki , Ogura, Yuki , Hosoda, Yasuo, Kanai∥, Takanori

Mayo Clinic

Gastroenterology Report | October 6, 2021 | Volume: 9 | Issue: 6 | Pages: 543-551

10.1093/gastro/goab042 | PMID 34925851 Get It

Abstract Background Guidelines recommend that all patients with upper gastrointestinal bleeding (UGIB) undergo endoscopy within 24 h. It is unclear whether a subgroup may benefit from an urgent intervention. We aimed to evaluate the influence of endoscopic hemostasis and urgent endoscopy on mortality in UGIB patients with high-risk stigmata (HRS). Methods Consecutive patients with suspected UGIB were enrolled in three Japanese hospitals with a policy to perform endoscopy within 24 h. The primary outcome was 30-day mortality. Endoscopic hemostasis and endoscopy timing (urgent, ≤6 h; early, &gt;6 h) were evaluated in a regression model adjusting for age, systolic pressure, heart rate, hemoglobin, creatinine, and variceal bleeding in multivariate analysis. A propensity score of 1:1 matched sensitivity analysis was also performed. Results HRS were present in 886 of 1966 patients, and 35 of 886 (3.95%) patients perished. Median urgent-endoscopy time (n = 769) was 3.0 h (interquartile range [IQR], 2.0–4.0 h) and early endoscopy (n = 117) was 12.0 h (IQR, 8.5–19.0 h). Successful endoscopic hemostasis and urgent endoscopy were significantly associated with reduced mortality in multivariable analysis (odds ratio [OR], 0.22; 95% confidence interval [CI], 0.09–0.52; P = 0.0006, and OR, 0.37; 95% CI, 0.16–0.87; P = 0.023, respectively). In a propensity-score-matched analysis of 115 pairs, adjusted comparisons showed significantly lower mortality of urgent vs early endoscopy (2.61% vs 7.83%, P &lt; 0.001). Conclusions A subgroup of UGIB patients, namely those harboring HRS, may benefit from endoscopic hemostasis and urgent endoscopy rather than early endoscopy in reducing mortality. Implementing triage scores that predict the presence of such lesions is important.
Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States
Solomon, Andrew , Kaisey, Marwa , Krieger, Stephen, Chahin, Salim , Weinstein, Sarah M. , Weinstein, Sarah M , Naismith, Robert T. , Shinohara, Russell Taki , Weinshenker, Brian G.

Mayo Clinic

Multiple Sclerosis Journal | October 6, 2021 | Volume: 28 | Issue: 8 | Pages: 1248-1256

10.1177/13524585211048401 | PMID 34612110 Get It

Background: Few studies have addressed the results of educational efforts concerning proper use of McDonald criteria (MC) revisions outside multiple sclerosis (MS) subspecialty centers. Neurology residents and MS subspecialist neurologists demonstrated knowledge gaps for core elements of the MC in a recent prior study. Objective: To assess comprehension and application of MC core elements by non-MS specialist neurologists in the United States who routinely diagnose MS. Methods: Through a cross-sectional study design, a previously developed survey instrument was distributed online. Results: A total of 222 neurologists completed the study survey. Syndromes atypical for MS were frequently incorrectly considered “typical” MS presentations. Fourteen percent correctly identified definitions of both “periventricular” and “juxtacortical” lesions and 2% correctly applied these terms to 9/9 images. Twenty-four percent correctly identified all four central nervous system (CNS) regions for satisfaction of magnetic resonance imaging (MRI) dissemination in space. In two presented cases, 61% and 71% correctly identified dissemination in time (DIT) was not fulfilled, and 85% and 86% subsequently accepted nonspecific historical symptoms without objective evidence for DIT fulfillment. Conclusion: The high rate of knowledge deficiencies and application errors of core elements of the MC demonstrated by participants in this study raise pressing questions concerning adequacy of dissemination and educational efforts upon publication of revisions to MC.